Knobbe Martens Partners Honored as 2027 IAM Global Leaders
IRVINE, Calif., October 23, 2026 – Knobbe Martens is pleased to share that partners Sabing Lee, Salima Merani, Ph.D., and Joseph Re have been featured in the 2027 IAM Global...
Knobbe Martens Earns Multiple Shortlistings at 2026 Financial Times Innovative Lawyers Awards
IRVINE, Calif., October 13, 2026 – Knobbe Martens has been shortlisted as among the country’s most innovative law firms at the 2026 Financial Times Innovative Lawyers North America Awards. The...
FDA Announces New Rare Disease Framework With Potential Implications for IP Strategy
Key Takeaway: On October 14, 2026, the FDA announced a proposed framework for rare disease drug development that aims to provide greater regulatory flexibility and disease-tailored evaluation. Increased regulatory clarity...
Subscribe for News and Updates